Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutex HealthFRA:5LF +3.77%57 Return-on-Tangible-Equity is 78.59% as of Jun. 2026, which is 2% above its 10-year median of 77.00. GuruFocus rates FRA:5LF with a GF Score™ of 57/100 and a GF Value™ of €70.29 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 583 Healthcare Providers & Services companies, Nutex Health ranks better than 83.36% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Nutex Health's annualized net income for the quarter that ended in Jun. 2026 was €228.6 Mil. Nutex Health's average shareholder tangible equity for the quarter that ended in Jun. 2026 was €290.9 Mil. Therefore, Nutex Health's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 78.59%.
The historical rank and industry rank for Nutex Health's Return-on-Tangible-Equity or its related term are showing as below:
FRA:5LF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -498.3 Med: 77 Max: 189.5
Current: 61.88
During the past 7 years, Nutex Health's highest Return-on-Tangible-Equity was 189.50%. The lowest was -498.30%. And the median was 77.00%.
FRA:5LF's Return-on-Tangible-Equity is ranked better than 83.36% of 583
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs FRA:5LF: 61.88
Nutex Health (FRA:5LF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Nutex Health Return-on-Tangible-Equity Related Terms
Nutex Health Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Nutex Health's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5LF vs USPH, AMN, GMRS: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Nutex Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutex Health Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Nutex Health's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 78.59% mean?
Nutex Health (FRA:5LF) has a Return-on-Tangible-Equity of 78.59% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Nutex Health and its competitors. This is near median its historical median of 77.00. According to the industry distribution chart, Nutex Health ranks #97 out of 583 companies in the Healthcare Providers & Services industry, placing it in the top 16.6%.
Is Nutex Health's Return-on-Tangible-Equity too high?
Nutex Health's current Return-on-Tangible-Equity of 78.59% is near median its 10-year median of 77.00. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.76. Nutex Health's value of 78.59% is 630.4% above this industry median. Based on the distribution chart, Nutex Health ranks #97 out of 583 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nutex Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's Return-on-Tangible-Equity compare to USPH and AMN?
According to the Healthcare Providers & Services industry distribution chart, Nutex Health ranks #97 out of 583 companies for Return-on-Tangible-Equity. This places Nutex Health in the top 17% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.76. Nutex Health's value of 78.59% is 630.4% above this benchmark. While the company's 10-year median is 77.00 vs. the industry median of 10.76, Nutex Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.76, based on 583 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutex Health's current Return-on-Tangible-Equity of 78.59% is 630.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Nutex Health and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutex Health's current Return-on-Tangible-Equity is 78.59%, which is near median its own 10-year median of 77.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (FRA:5LF) is currently considered Significantly Overvalued. The stock's GF Value™ is €70.29, compared to a current price of €165.00 — trading 134.7% above its estimated fair value. The current Return-on-Tangible-Equity is 78.59%, which is near median its 10-year median of 77.00 and 630.4% above the Healthcare Providers & Services industry median of 10.76. Nutex Health's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Nutex Health (FRA:5LF), the current Return-on-Tangible-Equity is 78.59% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutex Health (FRA:5LF) Overvalued in 2026?
Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued.
The current stock price of €165.00 is trading 134.7% above its estimated GF Value™ of €70.29.
GuruFocus considers Nutex Health to be Significantly Overvalued.
Key valuation signals for FRA:5LF:
Return-on-Tangible-Equity: 78.59% (near median its 10-year median of 77.00)
GF Value™: €70.29 vs. price of €165.00 (134.7% above fair value)
Industry Position: 630.4% above the Healthcare Providers & Services median (#97 of 583)
No single metric tells the full story. See the FRA:5LF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
57GF Score
Get the complete analysis for FRA:5LF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5LF has been successfully added to your 
